Kohlberg Kravis Roberts & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
OS
OneStream Inc
OS
|
+$3.2B |
| 2 |
BrightSpring Health Services
BTSG
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BridgeBio Pharma
BBIO
|
+$152M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$16.1M |
| 3 |
Viasat
VSAT
|
+$4.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 53.21% |
| 2 | Healthcare | 27.5% |
| 3 | Industrials | 7.01% |
| 4 | Real Estate | 1.65% |
| 5 | Communication Services | 1.09% |
Similar funds
Kohlberg Kravis Roberts & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Kohlberg Kravis Roberts & Co held 74 positions worth $7.47B, up 124% from $3.33B the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Kohlberg Kravis Roberts & Co deployed $2.53B of net new capital in Q3 2024, opening 1 new position and adding to 1 existing holding. Its largest new stake was OneStream Inc: 108,745,114 shares worth $3.69B.
By sector, the portfolio is most concentrated in Technology at 53% of assets, up from 6.5% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was BridgeBio Pharma, an estimated $152M trimmed.
- Kohlberg Kravis Roberts & Co's largest Q3 2024 buy was OneStream Inc: 108,745,114 shares worth $3.69B.
- Kohlberg Kravis Roberts & Co added most to BrightSpring Health Services in Q3 2024, an estimated $146M increase.
- Kohlberg Kravis Roberts & Co's biggest Q3 2024 reduction was BridgeBio Pharma, cutting an estimated $152M.
- Kohlberg Kravis Roberts & Co fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2024, selling an estimated $16.1M.
- Kohlberg Kravis Roberts & Co's ten largest holdings make up 94% of its $7.47B portfolio in Q3 2024.
- Kohlberg Kravis Roberts & Co opened 1 new position and closed 2 in Q3 2024.
- Kohlberg Kravis Roberts & Co's portfolio value rose 124% quarter-over-quarter to $7.47B.
Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2024, filed 14 Nov 2024.